Refine
Has Fulltext
- yes (154)
Is part of the Bibliography
- yes (154)
Year of publication
Document Type
- Journal article (106)
- Doctoral Thesis (48)
Keywords
- Tissue Engineering (24)
- tissue engineering (10)
- in vitro (5)
- regenerative medicine (5)
- stem cells (5)
- 3D tissue model (4)
- In-vitro-Kultur (4)
- extracellular matrix (4)
- gene expression (4)
- inflammation (4)
- BMP-2 (3)
- Bordetella pertussis (3)
- In vitro (3)
- Stammzelle (3)
- Zellkultur (3)
- bone regeneration (3)
- chondrocytes (3)
- collagens (3)
- decellularization (3)
- electrospinning (3)
- 3D tumour model (2)
- B cells (2)
- BMP (2)
- Bone morphogenetic protein-2 (2)
- Cancer (2)
- Dünndarm (2)
- Elektrospinnen (2)
- Fibroblasts (2)
- GMP (2)
- Gewebekultur (2)
- Hautmodell (2)
- Hirschsprung disease (2)
- Hyaliner Knorpel (2)
- Immuntherapie (2)
- Implantat (2)
- Kollagen (2)
- Kreuzband (2)
- Ligamentum cruciatum anterius (2)
- Medizinprodukt (2)
- Melanom (2)
- Mundschleimhaut (2)
- Neisseria gonorrhoeae (2)
- Osteoarthritis (2)
- Raman-Spektroskopie (2)
- Regenerative Medizin (2)
- SARS-CoV-2 (2)
- Tumormodell (2)
- Validierung (2)
- Vaskularisation (2)
- Vaskularisierung (2)
- Wundheilung (2)
- anthocyanins (2)
- bioengineering (2)
- biological models (2)
- bioreactor (2)
- blood-brain barrier (BBB) model (2)
- burn wound (2)
- cartilage (2)
- cartilage regeneration (2)
- co-culture (2)
- colorectal cancer (2)
- discriminant analysis (2)
- extracellular vesicles (2)
- growth factor beta (2)
- immunotherapy (2)
- impedance spectroscopy (2)
- infection (2)
- intestinal in vitro model (2)
- invasion (2)
- lung cancer (2)
- mesenchymal stem cells (2)
- multiple myeloma (2)
- osteoarthritis (2)
- pancreas (2)
- permeability (2)
- phenotype (2)
- principal component analysis (2)
- raman spectroscopy (2)
- rat (2)
- reconstructed human epidermis (2)
- scaffolds (2)
- subcutaneous animal model (2)
- targeted therapy (2)
- therapy (2)
- vascularization (2)
- wound healing (2)
- 1st-line treatment (1)
- 3D (1)
- 3D Modell (1)
- 3D Tumormodell (1)
- 3D in vitro Modell (1)
- 3D in vitro model (1)
- 3D in vitro models (1)
- 3D lung tumor tissue models (1)
- 3D model (1)
- 3D models (1)
- 3D scaffolds (1)
- 3D tissue models (1)
- 3D-Elektrode (1)
- 3D-Kultur (1)
- 5-Fluorouracil (1)
- ACL construct (1)
- ATMP (1)
- Adenocarcinom (1)
- Adenokarzinom (1)
- Adenylate cyclase toxin (1)
- Advanced Therapy Medicinal Products (ATMP) (1)
- Akute myeloische Leukämie (1)
- Alternative test methods (1)
- Alternative zum Tierversuch (1)
- Alzheimer′s disease (1)
- Anastomoseninsuffizienz (1)
- Angiogenese (1)
- Anterior Cruciate Ligament (1)
- Antikörper (1)
- Apoptosis (1)
- Arthroseentstehung (1)
- Articular-Cartilage (1)
- Arzneimittel (1)
- Arzneimittelzulassung (1)
- Assay (1)
- Atemwege (1)
- Atemwegsschleimhaut (1)
- Automation (1)
- B cell receptors (1)
- BMP signaling (1)
- BMP-2 delivery (1)
- BRAF mutation (1)
- BRAF-mutant (1)
- BRAF-mutiert (1)
- BSGC (1)
- Bakterielle Nanocellulose (1)
- Bauchspeicheldrüse (1)
- Beta-catenin (1)
- Bindegewebe (1)
- BioVaSc (1)
- Biocompatibility (1)
- Biodegradable polymer scaffolds (1)
- Biodistribution (1)
- Biokompatibilität (1)
- Biomaterial (1)
- Biomechanical Properties (1)
- Biomedical engineering (1)
- Bioreactor (1)
- Bone morphogenetic protein 2 (1)
- Bone tissue engineering (1)
- Brustkrebs (1)
- CAR T cell (1)
- CCR2 (1)
- CCR4 (1)
- CNS disease (1)
- CYP induction (1)
- CYP inhibition (1)
- CYR61 (1)
- Caco2 cells (1)
- Carcinoma cells (1)
- Cardiac ventricles (1)
- Cell replacement therapy (1)
- Chemicals (1)
- Collagen (1)
- Compressive Properties (1)
- Cytokeratine (1)
- Data acquisition (1)
- Dezellularisierung (1)
- Diabetes mellitus (1)
- Dickdarmtumor (1)
- Diffusion tensor imaging (1)
- Dosis-Wirkungs-Beziehung (1)
- Draize eye test (1)
- Drug testing (1)
- ECM coating (1)
- EMT (1)
- EVs (1)
- Eigenvectors (1)
- Eisenoxid-Nanopartikel (1)
- Electrochemical Impedance Spectroscopy (1)
- Electrode (1)
- Electrospinning (1)
- Elektrode (1)
- Enteric nervous system (1)
- Enteric neuropathies (1)
- Entwicklung (1)
- Epidermis (1)
- Epidermismodell (1)
- Episkin (1)
- Epithel (1)
- Eriodictyon californicum (1)
- Extrazellulärmatrix (1)
- Eye irritation (1)
- FGF signaling (1)
- FTIR spectroscopy (1)
- Fibroblast (1)
- Fibrose (1)
- Fluorouracil (1)
- Fremdkörpermodell (1)
- GDF-5 (1)
- GLP-1 (1)
- GLUTs (1)
- GUT (1)
- Gastrointestinaltrakt (1)
- Gefitinib (1)
- Gelatine (1)
- Gene regulation (1)
- Gewebemodell (1)
- Gewebemodelle (1)
- Glucose transport (1)
- Growth; BMP-2 (1)
- HUVEC (1)
- Halofuginon (1)
- Haut (1)
- Hautverbrennung (1)
- Head and neck cancers (1)
- Heart (1)
- Hemofiltration (1)
- Herzschrittmacher (1)
- Hirschsprung disease liability (1)
- Human Knee (1)
- Human Medial Meniscus (1)
- Humanparasitologie (1)
- Hydrogel (1)
- Hypertrophic pyloric-stenosis (1)
- Hämophilie A (1)
- IL-1ß (1)
- IL-6 (1)
- In vitro skin irritation testing (1)
- In-vitro (1)
- In-vitro-Testsystem (1)
- In-vivo (1)
- Individualisierte Medizin (1)
- Induced pluripotent stem cells (1)
- Induzierte pluripotente Stammzelle (1)
- Infektionsstudien (1)
- Injuries (1)
- Intestinal pseudoobstruction (1)
- Intestinal stem cell (1)
- Invasion (1)
- Irritable bowel syndrome (1)
- Ischämie (1)
- KRAS biomarker signatures (1)
- Kernspintomografie (1)
- Kniegelenk (1)
- Knochenimplantat (1)
- Knochenregeneration (1)
- Knorpelimplantate (1)
- Kohlenstoff (1)
- Kohlenstofffaser (1)
- Krebs <Medizin> (1)
- Kreuzbandersatz (1)
- Kryokonservierung (1)
- Künstliche Ingelligenz (1)
- LCST (1)
- LDH-assay (1)
- Lactatdehydrogenase (1)
- Lgr5 (1)
- Lungenkrebs (1)
- Lungentumor (1)
- MRT (1)
- MSC (1)
- Magen (1)
- Magenchirurgie (1)
- Magenkrankheit (1)
- Magnet-Partikel-Spektroskopie (1)
- Magnetic resonance imaging (1)
- Mamma carcinoma (1)
- Mammakarzinom (1)
- Mandibular continuity defects (1)
- Marketing authorisation of pharmaceuticals (1)
- Marrow stromal cells (1)
- Matrix (1)
- Mechanical deformation (1)
- Mechanisms (1)
- Medicine (1)
- Mesenchymal Stem Cell (1)
- Mesenchymal transition (1)
- Mesenchymale Stammzellen (1)
- Microenvironment (1)
- Mikrowellen (1)
- Minipig (1)
- Model (1)
- Models (1)
- Molekularbiologie (1)
- Monitoring (1)
- Mukosamodell (1)
- Multicenter randomized-trial (1)
- Multilayered skin tissue model (1)
- Mundschleimhautäquivalent (1)
- Myofibroblast differentiation (1)
- NK cells (1)
- NMR (1)
- NOTCH (1)
- NOTES <Chirurgie> (1)
- NRAS mutation (1)
- Nanofaser (1)
- Neisseria meningitidis (1)
- Neuartige Arzneimittel (1)
- Neural crest cells (1)
- Nitric-oxide (1)
- OECD guideline (1)
- OLFM4 (1)
- Onchocerca volvulus (1)
- Onchozerkose (1)
- Open source reconstructed epidermis (1)
- Oral squamous cell carcinoma (1)
- Oralmukosa (1)
- Oralmukosamodell (1)
- Oxide synthase gene (1)
- PLGA (1)
- Paclitaxel (1)
- Pancreatic islet (1)
- Pankreas (1)
- Pankreaskarzinom (1)
- Parasitology (1)
- Partikel (1)
- Perforation <Medizin> (1)
- Perfusion Bioreactor (1)
- Plattenepithelcarcinom (1)
- Pleuramesotheliom (1)
- Polylactid-co-Glycolid (1)
- Preclinical studies (1)
- Primär-basierte immortalisierte Zelllinie (1)
- Primäre Ziliendyskinesie (1)
- Proliferation (1)
- Protein chemistry (1)
- Protein-Tyrosin-Kinasen (1)
- Präklinische Studien (1)
- QPCR (1)
- R57A (1)
- RHE (1)
- RT-qPCR (1)
- Rat mynteric plexus (1)
- Real time quantitative PCR (1)
- Receptor (1)
- Repair (1)
- Reperfusion (1)
- Resistenzentwicklung (1)
- Respiratorisches System (1)
- SGLTs (1)
- SIS/MUC (1)
- Salinomycin (1)
- Salmonella (1)
- Salmonella Typhimurium (1)
- Scaffold bone implant (1)
- Sglt1 (1)
- Silikon (1)
- Sinus floor augmentation (1)
- Skin Tissue Engineering (1)
- Slow-transit constipation (1)
- Smooth-muscle-cells (1)
- Squamous-cell carcinoma (1)
- Stammzellforschung (1)
- Stem cells (1)
- Stem-cell biotechnology (1)
- Stimulation (1)
- Stroma (1)
- Swine (1)
- T-Zell-rekrutierende Antikörperkonstrukte (1)
- TEER (1)
- TEER-Wert (1)
- TGF-beta (1)
- TGFβ/BMP signaling (1)
- TNBC (1)
- Targeted therapies (1)
- Term follow-up (1)
- Test system (1)
- Therapeutisches System (1)
- Therapie (1)
- Therapiesimulation (1)
- Tipifarnib (1)
- Tissue (1)
- Tractography (1)
- Triple co-culture (1)
- Tumor models (1)
- Tumorigenicity (1)
- Tumormikroumgebung (1)
- Tumorzelllinien (1)
- Validation (1)
- Vascularized (1)
- Viabilität (1)
- Vivo (1)
- Vorderes Kreuzband (1)
- Wirkstofftestung (1)
- Zell-Migration (1)
- Zelldifferenzierung (1)
- Zellkulturmodell (1)
- acetylsalicylic acid (1)
- acid dissociation (1)
- acute myeloid leukemia (1)
- adenocarcinoma of the lung (1)
- adenylate cyclase toxin (1)
- adhesion (1)
- adults (1)
- aging (1)
- air-liquid interface (1)
- airway epithelia (1)
- airways (1)
- albumins (1)
- algorithm (1)
- alternative to animal testing (1)
- alternatives (1)
- anaesthetics (1)
- anatomy (1)
- animal model (1)
- antagonist (1)
- antennas (1)
- anthocyanin (1)
- antibiotics (1)
- antioxidative (1)
- antitumor peptide (1)
- antiviral activity (1)
- apoptosis (1)
- artificial membrane-permeability (1)
- aspirin (1)
- astaxanthin (1)
- asthmatic bronchial epithelium (1)
- astrocytes (1)
- autologous (1)
- autologous chondrocyte implantation (1)
- automation (1)
- automation & robotics (1)
- bacteria (1)
- bacterial cellulose dressing (1)
- bacterial migration (1)
- bacterial nanocellulose (1)
- bacterial virulence (1)
- barrier models (1)
- benzalkonium chloride (1)
- beta cell (1)
- beta-aminopropionitrile (1)
- beta-cyclodextrin (1)
- betaglycan (1)
- bilberry (1)
- biocompatibility (1)
- biocompatible materials (1)
- bioconjugation (1)
- biofilm (1)
- bioinformatics (1)
- biological barriers (1)
- biological scaffold (1)
- biological scaffolds (1)
- biology (1)
- biomaterial tests (1)
- biomedical engineering (1)
- biomedical materials (1)
- biomimetic 3D tissue model (1)
- bioreactor culture (1)
- biotechnology (1)
- black currant (1)
- blood (1)
- blood glucose regulation (1)
- blood pressure (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- blood‐brain barrier (BBB) (1)
- bone (1)
- bone critical size defect (1)
- bone marrow (1)
- bone morphogenetic protein (1)
- bone morphogenetic protein 2 (BMP2) (1)
- bone morphogenetic protein 9 (BMP9) (1)
- bone morphogenetic proteins (1)
- boolean in silico models (1)
- brachtydacyly type A2 (1)
- brain endothelial cells (1)
- brain–liver chip (1)
- breast cancer cells (1)
- calcium fluoride nanoparticles (1)
- cancer dissemination (1)
- cancer treatment (1)
- cancers and neoplasms (1)
- carbon fiber (1)
- cardiac device therapy (1)
- cardiac patch (1)
- cardiac tissue (1)
- cardiovascular (1)
- cardiovascular MR methods (1)
- cartilage defectex vivo model (1)
- cartilage test system (1)
- cell binding (1)
- cell culture (1)
- cell cultures (1)
- cell cycle and cell division (1)
- cell differentiation (1)
- cell engineering (1)
- cell membrane model (1)
- cell metabolism (1)
- cell migration (1)
- cell proliferation (1)
- cellular biology (1)
- cellular microenvironment (1)
- cellular signalling networks (1)
- central nervous system (1)
- ceramide (1)
- chemokine receptor (1)
- chiral resolution (1)
- chondrogenesis (1)
- chondrogenic differentiation (1)
- chondrogenic hypertrophy (1)
- ciliary neurotrophic factor (1)
- ciliostasis (1)
- circular dichroism (1)
- clinical applications (1)
- collagen sponge (1)
- collagen type I hydrogel (1)
- colllagen (1)
- colon (1)
- colony-stimulating factor (1)
- combination of physical vapor deposition and electrochemical etching (1)
- combinatorial drug predictions (1)
- complexation (1)
- computer modelling (1)
- confocal Raman imaging (1)
- core depression (1)
- coreceptor (1)
- corneal endothelium (1)
- corneal epithelium (1)
- corneal equivalent (1)
- corneal storage (1)
- covalent coupling (1)
- cross-talk (1)
- cryokonservation (1)
- cryostructured scaffolds (1)
- crystal structure (1)
- crystal-structure (1)
- culture techniques (1)
- cultured (1)
- cyclic adenosine monophosphate (1)
- cycloaddition (1)
- cyclodextrin (1)
- cytokine (1)
- cytokines (1)
- cytotoxicity (1)
- defects (1)
- defined humanized test system (1)
- dendritic cell (1)
- development (1)
- diabetes (1)
- differentiation (1)
- diffusion tensor imaging (1)
- dominant-negative mutatio (1)
- drug (1)
- drug delivery (1)
- drug metabolism (1)
- drug permeability screening (1)
- drug resistance (1)
- dry spinning (1)
- dynamic culture (1)
- dynamic culture conditions (1)
- dystrophic RCS rats (1)
- early diagnosis (1)
- ectopic bone formation (1)
- elastic fibers (1)
- elastin (1)
- electrical and electronic engineering (1)
- electrode scaffold (1)
- embryonic stem cell (1)
- embryonic stem cells (1)
- endothelial cells (1)
- endothelial growth factor (1)
- enteric nervous system (1)
- enzyme metabolism (1)
- epidermis (1)
- epithelial cell culture (1)
- epithelial cells (1)
- equipment and supplies (1)
- establishment (1)
- experimental models of disease (1)
- expression (1)
- eye irritation testing (1)
- factor binding profiles (1)
- factor-VIII (1)
- fibroblast chemotaxis (1)
- fibroblast growth factor (1)
- fibrosis (1)
- filamentous Salmonella Typhimurium (1)
- fixation (1)
- flavonoids (1)
- foreign body reaction (1)
- formalin (1)
- fremdkörper assoziierte Reaktion (1)
- full thickness skin (1)
- functional initiators (1)
- gamma-cyclodextrin (1)
- gastrointestinal tract (1)
- gels (1)
- gene encoding noggin (1)
- gene therapy (1)
- genetic engineering (1)
- glucose (1)
- glycoprotein (1)
- growth and differentiation factor 5 (1)
- hBMSC (1)
- head and neck squamous cell carcinoma (1)
- heart structure (1)
- heart valve (1)
- heparin binding sites (1)
- heptaocytes (1)
- herpesvirus (1)
- highly porous materials (1)
- host (1)
- human (1)
- human airway mucosa tissue models (1)
- human bruchs membrane (1)
- human exposure (1)
- human heptocytes (1)
- human induced pluripotent stem cells (hiPSCs) (1)
- human induced pluripotent stem cells (hiPSCs)human induced pluripotent stem cells (hiPSCs) (1)
- human liver cells (1)
- human nasal epithelial cells (1)
- human osteosarcoma xenografts (1)
- human respiratory epithelial cells (1)
- human tracheo-bronchial epithelial cells (1)
- humane mesenchymale Stammzellen (1)
- human‐induced pluripotent stem cells (hiPSC) (1)
- hyaline cartilage (1)
- hybrid pacemaker (1)
- hyperlipidemia (1)
- hypoxia inducible factor 1 (1)
- immune cell infiltration (1)
- immunotherapeutics (1)
- immunotherapies (1)
- implant (1)
- in silico simulation (1)
- in situ guided tissue regeneration (1)
- in vitro Modelle (1)
- in vitro model (1)
- in vitro models (1)
- in vitro-Testsystem (1)
- in vivo (1)
- in vivo experiments (1)
- in vivo study (1)
- in-vitro (1)
- in-vitro models (1)
- in-vitro-Modell (1)
- in-vitro-Testsysteme (1)
- induced pluripotent stem cells (1)
- induction (1)
- infectious disease (1)
- inflammation-induced tissue demage (1)
- inflammatory bowel disease (1)
- inflammatory response (1)
- insulin (1)
- interface (1)
- intestinal enteroids (1)
- intestine (1)
- invasiveness (1)
- invitro (1)
- inflammatory response (1)
- iron metabolism (1)
- irradiation (1)
- islets of Langerhans (1)
- kinetics (1)
- kolorektales Karzinom (1)
- label-free analysis (1)
- laser microdissection (1)
- ligand binding (1)
- ligand-receptor complex (1)
- ligand-receptor promiscuity (1)
- lipids (1)
- liposome (1)
- living cells (1)
- lncRNAs (1)
- long-term (1)
- lower critical solution temperature (1)
- lung and intrathoracic tumors (1)
- magnetic resonance imaging (MRI) (1)
- malignant tumors (1)
- manufacturing (1)
- measels virus (1)
- measles virus (1)
- mechanisms of disease (1)
- medicine (1)
- melanoma metastases (1)
- membrane receptor signaling (1)
- memory (1)
- meningococcus (1)
- mesenchymal cells (1)
- mesenchymal stromal cell (1)
- mesenchymal tissues (1)
- metabolic flux analysis (1)
- metallo-supramolecular polymer (1)
- miRNAs (1)
- microbe carrier (1)
- microenvironment (1)
- microparticles (1)
- microphysiologic 3D tumour model (1)
- microphysiological systems (MPS) (1)
- microplastics (1)
- microvascular endothelial cells (1)
- microwave radiation (1)
- midazolam (1)
- migration (1)
- modular tumor tissue models (1)
- moisture balance (1)
- molecular biology (1)
- molecular diagnostics (1)
- molecular mechanism (1)
- morphogenetic protein receptors (1)
- motility disorders (1)
- multi-organ chip (1)
- multicellular tumor spheroids (1)
- multifunctional nanoparticles (1)
- multilayered skin (1)
- multimodal imaging (1)
- multipotent fetal neural stem cells (fNSCs) (1)
- multivariate data analysis (1)
- murine (1)
- mutagenesis (1)
- myenteric plexus (1)
- nanoparticles (1)
- nanoplastics (1)
- nanotopographical surfaces (1)
- necrosis-factor-alpha (1)
- necrotic cell death (1)
- neural stem-cell (1)
- neurology (1)
- neuronal electrodes (1)
- neurotoxicity (1)
- neurovascular unit in vitro (1)
- neutrophil transmigration (1)
- non-invasive biomarkers (1)
- occupancy (1)
- olfactomedin 4 (1)
- on-a-chip (1)
- open-access database (1)
- open-source epidermis (1)
- oragnoids (1)
- oral mucosa model (1)
- orales Plattenepithelkarzinomäquivalent (1)
- organ-on-a-chip (1)
- organotypic (1)
- osteoblasts (1)
- osteochondral allografts (1)
- osteochondral lesion (1)
- osteogenesis imperfecta (1)
- osteogenic differentiation (1)
- osteoporosis (1)
- outgrowth endothelial cells (1)
- ovarian cancer (1)
- oxidative DNA damage (1)
- pancreatic cancer (1)
- pancreatic differentiation (1)
- parasitology (1)
- perfused hydrogel (1)
- perfusion-based bioreactor system (1)
- peritoneal metastasis (1)
- pharmaceutical applications (1)
- phosphatidylserine (1)
- photoluminescence (1)
- physiology (1)
- platelet-derived growth factor (1)
- pluripotent stem cells (1)
- polymer (1)
- polymerization (1)
- polymers (1)
- polypeptoids (1)
- postpolymerization modification (1)
- precision-cut lung slices (1)
- preclinical drug discovery (1)
- primary cell isolation (1)
- primary cells (1)
- primary ciliary dyskinesia (1)
- primary human hepatocytes (1)
- primary-cell-derived immortalized cell line (1)
- progenitor cells (1)
- progenitors (1)
- protein immobilization (1)
- proteins (1)
- pulmonary drug-delivery (1)
- pulmonary imaging (1)
- pulses (1)
- quanititative characterization (1)
- quantification (1)
- randomized clinical trial (1)
- reactive oxygen species (1)
- real time PCR (1)
- receptor type III (1)
- reflection (1)
- rekombinante Spinnseide (1)
- relaxometry (1)
- repair (1)
- respiratory syncytial virus (1)
- responses (1)
- retinal pigment epithelium (1)
- rhBMP–2 (1)
- ring-opening polymerization (1)
- salicylic acid (1)
- salivary gland neoplasia (1)
- salivary gland tumor (1)
- salivary gland tumors (1)
- salivary glands (1)
- scaffold (1)
- scanning electron microscopy (1)
- secondary lung tumors (1)
- secondary wound dressing (1)
- segmental collapse (1)
- sevoflurane (1)
- sheep model (1)
- signal integration (1)
- signal specification (1)
- signal tranduction (1)
- signal transduction (1)
- signaling (1)
- signaling pathways (1)
- site directed immobilization (1)
- site-specific immobilization (1)
- skin anatomy (1)
- skin equivalent (1)
- skin equivalents (1)
- skin model (1)
- skin models (1)
- skin physiology (1)
- small intestinal submucosa (1)
- small intestinal submucosa scaffold (1)
- sodium channels (1)
- sol-gel chemistry (1)
- solid tumors (1)
- solid tumour (1)
- solubility (1)
- sphingosine-1-phosphate (1)
- starch (1)
- stemness (1)
- sterubin (1)
- stimulation (1)
- stratification (1)
- stromal cells (1)
- stromal tissues (1)
- subfoveal choroidal neovascularization (1)
- subretinal space (1)
- superfamily (1)
- supermolecular carrier systems (1)
- surgical oncology (1)
- systemic inflammatory response syndrome (1)
- t-cell recruting antibody constructs (1)
- targeted combination therapy (1)
- technology (1)
- therapy simulation (1)
- tight junction (1)
- tissue culture (1)
- tissue model (1)
- tissue preparation (1)
- tissue remodeling (1)
- toxicity (1)
- toxicology (1)
- trachea (1)
- tracheal cytotoxin (1)
- trafficking (1)
- transcapillary pressure gradient (1)
- transcriptomics (1)
- transforming growth factor-beta 1 (1)
- translational research (1)
- translocation (1)
- transplantation (1)
- transport studies (1)
- tumor cells (1)
- tumor model systems (1)
- tumor test system (1)
- tumormicroenvironment (1)
- tumour (1)
- tumour microenvironment (1)
- tumour stroma (1)
- upcyte hepatocytes (1)
- validation (1)
- vascular normalization (1)
- vascular surgery (1)
- vascularized scaffold (1)
- vesicle-based barrier (1)
- viability (1)
- viral epidemiology (1)
- viral infection (1)
- virulence (1)
- weight-bearing (1)
- wound model (1)
- wound physiology (1)
- xenotransplantation (1)
- zielgerichtete Behandlung (1)
- zinc oxide nanoparticles (1)
- α-Cell (1)
- β-Cell (1)
Institute
- Lehrstuhl für Tissue Engineering und Regenerative Medizin (154) (remove)
Sonstige beteiligte Institutionen
- Fraunhofer (1)
- Fraunhofer Institute Interfacial Engineering and Biotechnology (IGB) (1)
- Fraunhofer Institute for Integrierte Schaltungen (IIS) (1)
- IZKF (Interdisziplinäres Zentrum für Klinische Forschung), Universität Würzburg (1)
- Medizinische Universität Innsbruck (1)
- New York Blood Center (1)
- Queensland University of Technology (1)
Over the last 20 years, there has been increasing focus on the development of novel stem cell based therapies for the treatment of disorders and diseases affecting the enteric nervous system (ENS) of the gastrointestinal tract (so-called enteric neuropathies). Here, the idea is that ENS progenitor/stem cells could be transplanted into the gut wall to replace the damaged or absent neurons and glia of the ENS. This White Paper sets out experts' views on the commonly used methods and approaches to identify, isolate, purify, expand and optimize ENS stem cells, transplant them into the bowel, and assess transplant success, including restoration of gut function. We also highlight obstacles that must be overcome in order to progress from successful preclinical studies in animal models to ENS stem cell therapies in the clinic.
Transmission of Trypanosoma brucei by tsetse flies involves the deposition of the cell cycle-arrested metacyclic life cycle stage into mammalian skin at the site of the fly’s bite. We introduce an advanced human skin equivalent and use tsetse flies to naturally infect the skin with trypanosomes. We detail the chronological order of the parasites’ development in the skin by single-cell RNA sequencing and find a rapid activation of metacyclic trypanosomes and differentiation to proliferative parasites. Here we show that after the establishment of a proliferative population, the parasites enter a reversible quiescent state characterized by slow replication and a strongly reduced metabolism. We term these quiescent trypanosomes skin tissue forms, a parasite population that may play an important role in maintaining the infection over long time periods and in asymptomatic infected individuals.
Malignant melanoma (MM) is the most dangerous type of skin cancer with rising incidences worldwide. Melanoma skin models can help to elucidate its causes and formation or to develop new treatment strategies. However, most of the current skin models lack a vasculature, limiting their functionality and applicability. MM relies on the vascular system for its own supply and for its dissemination to distant body sites via lymphatic and blood vessels. Thus, to accurately study MM progression, a functional vasculature is indispensable. To date, there are no vascularized skin models to study melanoma metastasis in vitro, which is why such studies still rely on animal experimentation.
In the present thesis, two different approaches for the vascularization of skin models are employed with the aim to establish a vascularized 3D in vitro full-thickness skin equivalent (FTSE) that can serve as a test system for the investigation of the progression of MM.
Initially, endothelial cells were incorporated in the dermal part of FTSEs. The optimal seeding density, a spheroid conformation of the cells and the cell culture medium were tested. A high cell density resulted in the formation of lumen-forming shapes distributed in the dermal part of the model. These capillary-like structures were proven to be of endothelial origin by staining for the endothelial cell marker CD31. The established vascularized FTSE (vFTSE) was characterized histologically after 4 weeks of culture, revealing an architecture similar to human skin in vivo with a stratified epidermis, separated from the dermal equivalent by a basement membrane indicated by collagen type IV. However, this random capillary-like network is not functional as it cannot be perfused.
Therefore, the second vascularization approach focused on the generation of a perfusable tissue construct. A channel was molded within a collagen hydrogel and seeded with endothelial cells to mimic a central, perfusable vessel. The generation and the perfusion culture of the collagen hydrogel was enabled by the use of two custom-made, 3D printed bioreactors. Histological assessment of the hydrogels revealed the lining of the channel with a monolayer of endothelial cells, expressing the cell specific marker CD31.
For the investigation of MM progression in vitro, a 3D melanoma skin equivalent was established. Melanoma cells were incorporated in the epidermal part of FTSEs, representing the native microenvironment of the tumor. Melanoma nests grew at the dermo-epidermal junction within the well stratified epidermis and were characterized by the expression of common melanoma markers. First experiments were conducted showing the feasibility of combining the melanoma model with the vFTSE, resulting in skin models with tumors at the dermo-epidermal junction and lumen-like structures in the dermis.
Taken together, the models presented in this thesis provide further steps towards the establishment of a vascularized, perfusable melanoma model to study melanoma progression and metastasis.
Multiple myeloma (MM) represents a haematological cancer characterized by the pathological hyper proliferation of antibody-producing B-lymphocytes. Patients typically suffer from kidney malfunction and skeletal disorders. In the context of MM, the transforming growth factor β (TGFβ) member Activin A was recently identified as a promoter of both accompanying symptoms. Because studies have shown that bone morphogenetic protein (BMP)-2-mediated activities are counteracted by Activin A, we analysed whether BMP2, which also binds to the Activin A receptors ActRII and ActRIIB but activates the alternative SMAD-1/5/8 pathway, can be used to antagonize Activin A activities, such as in the context of MM. Therefore three BMP2 derivatives were generated with modified binding activities for the type II (ActRIIB) and/or type I receptor (BMPRIA) showing either increased or decreased BMP2 activity. In the context of MM these BMP2 muteins show two functionalities since they act as a) an anti-proliferative/apoptotic agent against neoplastic B-cells, b) as a bone-formation promoting growth factor. The molecular basis of both activities was shown in two different cellular models to clearly rely on the properties of the investigated BMP2 muteins to compete for the binding of Activin A to the Activin type II receptors. The experimental outcome suggests new therapeutic strategies using BMP2 variants in the treatment of MM-related pathologies.
Unraveling the connection between fibroblast growth factor and bone morphogenetic protein signaling
(2018)
Ontogeny of higher organisms as well the regulation of tissue homeostasis in adult individuals requires a fine-balanced interplay of regulating factors that individually trigger the fate of particular cells to either stay undifferentiated or to differentiate towards distinct tissue specific lineages. In some cases, these factors act synergistically to promote certain cellular responses, whereas in other tissues the same factors antagonize each other. However, the molecular basis of this obvious dual signaling activity is still only poorly understood. Bone morphogenetic proteins (BMPs) and fibroblast growth factors (FGFs) are two major signal protein families that have a lot in common: They are both highly preserved between different species, involved in essential cellular functions, and their ligands vastly outnumber their receptors, making extensive signal regulation necessary. In this review we discuss where and how BMP and FGF signaling cross paths. The compiled data reflect that both factors synchronously act in many tissues, and that antagonism and synergism both exist in a context-dependent manner. Therefore, by challenging a generalization of the connection between these two pathways a new chapter in BMP FGF signaling research will be introduced.
Gonorrhea, a sexually transmitted disease caused by the bacteria Neisseria gonorrhoeae, is characterized by a large number of neutrophils recruited to the site of infection. Therefore, proper modeling of the N. gonorrhoeae interaction with neutrophils is very important for investigating and understanding the mechanisms that gonococci use to evade the immune response. We have used a combination of a unique human 3D tissue model together with a dynamic culture system to study neutrophil transmigration to the site of N. gonorrhoeae infection. The triple co-culture model consisted of epithelial cells (T84 human colorectal carcinoma cells), human primary dermal fibroblasts, and human umbilical vein endothelial cells on a biological scaffold (SIS). After the infection of the tissue model with N. gonorrhoeae, we introduced primary human neutrophils to the endothelial side of the model using a perfusion-based bioreactor system. By this approach, we were able to demonstrate the activation and transmigration of neutrophils across the 3D tissue model and their recruitment to the site of infection. In summary, the triple co-culture model supplemented by neutrophils represents a promising tool for investigating N. gonorrhoeae and other bacterial infections and interactions with the innate immunity cells under conditions closely resembling the native tissue environment.
Cancer is one of the leading causes of death worldwide. Current therapeutic strategies are predominantly developed in 2D culture systems, which inadequately reflect physiological conditions in vivo. Biological 3D matrices provide cells an environment in which cells can self-organize, allowing the study of tissue organization and cell differentiation. Such scaffolds can be seeded with a mixture of different cell types to study direct 3D cell-cell-interactions. To mimic the 3D complexity of cancer tumors, our group has developed a 3D in vitro tumor test system.
Our 3D tissue test system models the in vivo situation of malignant peripheral nerve sheath tumors (MPNSTs), which we established with our decellularized porcine jejunal segment derived biological vascularized scaffold (BioVaSc). In our model, we reseeded a modified BioVaSc matrix with primary fibroblasts, microvascular endothelial cells (mvECs) and the S462 tumor cell line For static culture, the vascular structure of the BioVaSc is removed and the remaining scaffold is cut open on one side (Small Intestinal Submucosa SIS-Muc). The resulting matrix is then fixed between two metal rings (cell crowns).
Another option is to culture the cell-seeded SIS-Muc in a flow bioreactor system that exposes the cells to shear stress. Here, the bioreactor is connected to a peristaltic pump in a self-constructed incubator. A computer regulates the arterial oxygen and nutrient supply via parameters such as blood pressure, temperature, and flow rate. This setup allows for a dynamic culture with either pressure-regulated pulsatile or constant flow.
In this study, we could successfully establish both a static and dynamic 3D culture system for MPNSTs. The ability to model cancer tumors in a more natural 3D environment will enable the discovery, testing, and validation of future pharmaceuticals in a human-like model.
Bei der zystischen Fibrose (CF) sowie der primären Ziliendyskinesie (PCD) handelt es sich um zwei seltene Erkrankungen, die unter anderem den mukoziliären Transport beeinträchtigen. CF gehört hierbei zu den am häufigsten vorkommenden angeborenen Stoffwechselerkrankungen, wobei Betroffene unter einem Defekt des Cystic Fibrosis Transmembrane Conductor Regulator (CFTR)-Gens leiden, der durch die Produktion von hochviskosem Sekret in muzinproduzierenden Organen, wie dem gastrointestinalen Trakt und der Lunge, gekennzeichnet ist. Patienten, die an PCD leiden, weisen Defekte in, zum jetzigen Zeitpunkt, ca. 38 bekannten und PCD-assoziierten Genen auf, die in strukturellen Defekten des ziliären Apparats und somit in dysfunktionalen Kinozilien resultieren. Da aktuell weder für die CF noch für die PCD eine Heilung möglich ist, steht bei der Therapie vor allem die Linderung der Symptome im Fokus. Grundlegendes Ziel ist der langfristige Erhalt der Lungenfunktion sowie die Prävention bakterieller Infekte. Als bisherige Modellsysteme zur Erforschung möglicher Therapeutika gelten Tiermodelle, die den humanen Phänotyp aufgrund von Speziesdiversität nicht vollständig abbilden können. Als vielversprechende Testsysteme für die zystische Fibrose gelten humane intestinale Organoidkulturen. Nachdem allerdings vorwiegend respiratorische Symptome für die Mortalität der Patienten verantwortlich sind, stellen CF-Atemwegsmodelle bessere Testsysteme für zukünftige Therapeutika dar. Atmungsorganoidkulturen wurden verwendet, um die CFTR-Funktionalität zu untersuchen, repräsentieren aber nicht vollständig die in vivo Situation. Deshalb werden zur Entwicklung neuer Therapiestrategien patientenspezifische 3D in vitro Testsysteme der humanen Atemwege benötigt, die insbesondere im Hinblick auf personalisierte Medizin ihren Einsatz finden. In der vorliegenden Arbeit wurde eine für den Lehrstuhl neue Methode zur Zellgewinnung aus nasalen Schleimhautabstrichen etabliert, die eine standardisierte Versorgung mit humanem Primärmaterial garantiert. Zur Generierung einer krankheitsspezifischen Zelllinie, wie beispielsweise einer PCD-Zelllinie mit Hilfe des CRISPR/Cas9-Systems, ist eine Atemwegszelllinie erforderlich, die die in vivo Situation vollständig repräsentiert. So wurden vier verschiedene respiratorische Epithelzelllinien (HBEC3-KT, Calu-3, VA10 und Cl-huAEC) auf ihren mukoziliären Phänotyp hin untersucht, wobei lediglich die Zelllinie HBEC3-KT in zilientragende Zellen differenzierte. Diese zeigten jedoch nur auf ca. 5 % der Modelloberfläche Kinozilien, wodurch die humane respiratorische Mukosa nicht komplett abgebildet werden konnte und die HBEC3-KT-Zelllinie keine geeignete Zelllinie zur Generierung einer PCD-Zelllinie darstellte. Mit Hilfe des Tissue Engineering war es möglich, 3D in vitro Testsysteme basierend auf zwei unterschiedlichen Matrices, der biologischen SIS (small intestinal submucosa) und der synthetischen Polyethylenterephthalat (PET)-Membran, aufzubauen. Es wurden 3D Atemwegstestsysteme mit humanen primären nasalen und tracheobronchialen Epithelzellen generiert. Ergänzend zu histologischen Untersuchungen und zur Charakterisierung spezifischer Marker des respiratorischen Systems mittels Immunfluoreszenz, wurde die Ultrastruktur der Modelle, mit speziellem Fokus auf ziliäre Strukturen, analysiert. Um Rückschlüsse auf die ziliäre Funktionalität ziehen zu können und somit eine hohe in vivo Korrelation zu bestätigen, wurde im Rahmen dieser Arbeit am Lehrstuhl für Tissue Engineering und Regenerative Medizin die Methode der Hochgeschwindigkeitsvideomikroskopie etabliert, welche die Analyse der Zilienschlagfrequenz sowie des mukoziliären Transports ermöglicht. Ebenfalls wurde der Einfluss von isotoner Kochsalzlösung und des � 2-adrenergen Agonisten Salbutamol, das vor allem als Bronchodilatator bei Asthmapatienten eingesetzt wird, auf die Zilienschlagfrequenz analysiert. Es konnte gezeigt werden, dass beide Substanzen den Zilienschlag im Atemwegsmodell erhöhen. Zur Generierung der Testsysteme der beiden seltenen Erkrankungen CF und PCD wurden Epithelzellen der betroffenen Patienten zunächst mittels nicht-invasiver Raman-Spektroskopie auf einen potentiellen Biomarker untersucht, welcher Einsatz in der Diagnostik der beiden Krankheiten finden könnte. Es konnte jedoch weder für die CF noch für die PCD ein Biomarker aufgedeckt werden. Jedoch zeigten PCD-Zellen eine geringe Auftrennung gegenüber nicht-PCD Zellen. Anschließend wurden 3D-Atemwegstestsysteme basierend auf Patientenzellen aufgebaut. Der Phänotyp der CF-Modelle wurde mittels immunhistologischer Färbung und der Analyse des gestörten mukoziliären Transports verifiziert. Strukturelle ziliäre Defekte konnten durch die ultrastrukturelle Analyse von Zilienquerschnitten in drei donorspezifischen PCD-Modellen identifiziert werden. Darüber hinaus konnte die ziliäre Funktionalität mit Hilfe der Hochgeschwindigkeitsvideomikroskopie nicht nachgewiesen werden. Zusammenfassend ist es in dieser Arbeit gelungen, eine neue Methode zur vollständigen Charakterisierung von 3D-Atemwegstestsystemen zu etablieren, die die Analyse der Zilienschlagfrequenz sowie des mukoziliären Transports ermöglicht. Es konnte erstmalig gezeigt werden, dass mit Hilfe des Tissue Engineering ein personalisiertes Krankheitsmodell für die PCD auf Segmenten eines dezellularisierten porzinen Jejunums generiert werden kann, das zukünftig ein Testsystem für potentielle Therapeutika darstellen kann.
To circumvent time-consuming clinical trials, testing whether existing drugs are effective inhibitors of SARS-CoV-2, has led to the discovery of Remdesivir. We decided to follow this path and screened approved medications "off-label" against SARS-CoV-2. Fluoxetine inhibited SARS-CoV-2 at a concentration of 0.8 mu g/ml significantly in these screenings, and the EC50 was determined with 387 ng/ml. Furthermore, Fluoxetine reduced viral infectivity in precision-cut human lung slices showing its activity in relevant human tissue targeted in severe infections. Fluoxetine treatment resulted in a decrease in viral protein expression. Fluoxetine is a racemate consisting of both stereoisomers, while the S-form is the dominant serotonin reuptake inhibitor. We found that both isomers show similar activity on the virus, indicating that the R-form might specifically be used for SARS-CoV-2 treatment. Fluoxetine inhibited neither Rabies virus, human respiratory syncytial virus replication nor the Human Herpesvirus 8 or Herpes simplex virus type 1 gene expression, indicating that it acts virus-specific. Moreover, since it is known that Fluoxetine inhibits cytokine release, we see the role of Fluoxetine in the treatment of SARS-CoV-2 infected patients of risk groups.
Bone morphogenetic proteins (BMPs) are involved in various aspects of cell-cell communication in complex life forms. They act as morphogens, help differentiate different cell types from different progenitor cells in development, and are involved in many instances of intercellular communication, from forming a body axis to healing bone fractures, from sugar metabolism to angiogenesis. If the same protein or protein family carries out many functions, there is a demand to regulate and fine-tune their biological activities, and BMPs are highly regulated to generate cell- and context-dependent outcomes.
Not all such instances can be explained yet. Growth/differentiation factor (GDF)5 (or BMP14) synergizes with BMP2 on chondrogenic ATDC5 cells, but antagonizes BMP2 on myoblastic C2C12 cells. Known regulators of BMP2/GDF5 signal transduction failed to explain this context-dependent difference, so a microarray was performed to identify new, cell-specific regulatory components. One identified candidate, the fibroblast growth factor receptor (FGFR)2, was analyzed as a potential new co-receptor to BMP ligands such as GDF5: It was shown that FGFR2 directly binds BMP2, GDF5, and other BMP ligands in vitro, and FGFR2 was able to positively influence BMP2/GDF5-mediated signaling outcome in cell-based assays. This effect was independent of FGFR2s kinase activity, and independent of the downstream mediators SMAD1/5/8, p42/p44, Akt, and p38. The elevated colocalization of BMP receptor type IA and FGFR2 in the presence of BMP2 or GDF5 suggests a signaling complex containing both receptors, akin to other known co-receptors of BMP ligands such as repulsive guidance molecules.
This unexpected direct interaction between FGF receptor and BMP ligands potentially opens a new category of BMP signal transduction regulation, as FGFR2 is the second receptor tyrosine kinase to be identified as BMP co-receptor, and more may follow. The integration of cell surface interactions between members of the FGF and BMP family especially may widen the knowledge of such cellular communication mechanisms which involve both growth factor families, including morphogen gradients and osteogenesis, and may in consequence help to improve treatment options in osteochodnral diseases.
Radioresistance is an important cause of head and neck cancer therapy failure. Zinc oxide nanoparticles (ZnO-NP) mediate tumor-selective toxic effects. The aim of this study was to evaluate the potential for radiosensitization of ZnO-NP. The dose-dependent cytotoxicity of ZnO-NP\(_{20 nm}\) and ZnO-NP\(_{100 nm}\) was investigated in FaDu and primary fibroblasts (FB) by an MTT assay. The clonogenic survival assay was used to evaluate the effects of ZnO-NP alone and in combination with irradiation on FB and FaDu. A formamidopyrimidine-DNA glycosylase (FPG)-modified single-cell microgel electrophoresis (comet) assay was applied to detect oxidative DNA damage in FB as a function of ZnO-NP and irradiation exposure. A significantly increased cytotoxicity after FaDu exposure to ZnO-NP\(_{20 nm}\) or ZnO-NP\(_{100 nm}\) was observed in a concentration of 10 µg/mL or 1 µg/mL respectively in 30 µg/mL of ZnO-NP\(_{20 nm}\) or 20 µg/mL of ZnO-NP\(_{100 nm}\) in FB. The addition of 1, 5, or 10 µg/mL ZnO-NP\(_{20 nm}\) or ZnO-NP\(_{100 nm}\) significantly reduced the clonogenic survival of FaDu after irradiation. The sub-cytotoxic dosage of ZnO-NP\(_{100 nm}\) increased the oxidative DNA damage compared to the irradiated control. This effect was not significant for ZnO-NP\(_{20 nm}\). ZnO-NP showed radiosensitizing properties in the sub-cytotoxic dosage. At least for the ZnO-NP\(_{100 nm}\), an increased level of oxidative stress is a possible mechanism of the radiosensitizing effect.
Due to the wide variety of benign and malignant salivary gland tumors, classification and malignant behavior determination based on histomorphological criteria can be difficult and sometimes impossible. Spectroscopical procedures can acquire molecular biological information without destroying the tissue within the measurement processes. Since several tissue preparation procedures exist, our study investigated the impact of these preparations on the chemical composition of healthy and tumorous salivary gland tissue by Fourier-transform infrared (FTIR) microspectroscopy. Sequential tissue cross-sections were prepared from native, formalin-fixed and formalin-fixed paraffin-embedded (FFPE) tissue and analyzed. The FFPE cross-sections were dewaxed and remeasured. By using principal component analysis (PCA) combined with a discriminant analysis (DA), robust models for the distinction of sample preparations were built individually for each parotid tissue type. As a result, the PCA-DA model evaluation showed a high similarity between native and formalin-fixed tissues based on their chemical composition. Thus, formalin-fixed tissues are highly representative of the native samples and facilitate a transfer from scientific laboratory analysis into the clinical routine due to their robust nature. Furthermore, the dewaxing of the cross-sections entails the loss of molecular information. Our study successfully demonstrated how FTIR microspectroscopy can be used as a powerful tool within existing clinical workflows.
Multiple myeloma (MM), a malignancy of the bone marrow, is characterized by a pathological increase in antibody-producing plasma cells and an increase in immunoglobulins (plasmacytosis). In recent years, bone morphogenetic proteins (BMPs) have been reported to be activators of apoptotic cell death in neoplastic B cells in MM. Here, we use bone morphogenetic protein 2 (BMP2) to show that the "apoptotic" effect of BMPs on human neoplastic B cells is dominated by anti-proliferative activities and cell cycle arrest and is apoptosis-independent. The anti-proliferative effect of BMP2 was analysed in the human cell lines KMS12-BM and L363 using WST-1 and a Coulter counter and was confirmed using CytoTox assays with established inhibitors of programmed cell death (zVAD-fmk and necrostatin-1). Furthermore, apoptotic activity was compared in both cell lines employing western blot analysis for caspase 3 and 8 in cells treated with BMP2 and FasL. Additionally, expression profiles of marker genes of different cell death pathways were analysed in both cell lines after stimulation with BMP2 for 48h using an RT-PCR-based array. In our experiments we observed that there was rather no reduction in absolute cell number, but cells stopped proliferating following treatment with BMP2 instead. The time frame (48–72 h) after BMP2 treatment at which a reduction in cell number is detectable is too long to indicate a directly BMP2-triggered apoptosis. Moreover, in comparison to robust apoptosis induced by the approved apoptotic factor FasL, BMP2 only marginally induced cell death. Consistently, neither the known inhibitor of apoptotic cell death zVAD-fmk nor the necroptosis inhibitor necrostatin-1 was able to rescue myeloma cell growth in the presence of BMP2.
A fine balance of regulatory (T\(_{reg}\)) and conventional CD4\(^+\) T cells (T\(_{conv}\)) is required to prevent harmful immune responses, while at the same time ensuring the development of protective immunity against pathogens. As for many cellular processes, sphingolipid metabolism also crucially modulates the T\(_{reg}\)/T\(_{conv}\) balance. However, our understanding of how sphingolipid metabolism is involved in T cell biology is still evolving and a better characterization of the tools at hand is required to advance the field. Therefore, we established a reductionist liposomal membrane model system to imitate the plasma membrane of mouse T\(_{reg}\) and T\(_{conv}\) with regards to their ceramide content. We found that the capacity of membranes to incorporate externally added azide-functionalized ceramide positively correlated with the ceramide content of the liposomes. Moreover, we studied the impact of the different liposomal preparations on primary mouse splenocytes in vitro. The addition of liposomes to resting, but not activated, splenocytes maintained viability with liposomes containing high amounts of C\(_{16}\)-ceramide being most efficient. Our data thus suggest that differences in ceramide post-incorporation into T\(_{reg}\) and T\(_{conv}\) reflect differences in the ceramide content of cellular membranes.
The human pathogen Bordetella pertussis targets the respiratory epithelium and causes whooping cough. Its virulence factor adenylate cyclase toxin (CyaA) plays an important role in the course of infection. Previous studies on the impact of CyaA on human epithelial cells have been carried out using cell lines derived from the airways or the intestinal tract. Here, we investigated the interaction of CyaA and its enzymatically inactive but fully pore-forming toxoid CyaA-AC– with primary human airway epithelial cells (hAEC) derived from different anatomical sites (nose and tracheo-bronchial region) in two-dimensional culture conditions. To assess possible differences between the response of primary hAEC and respiratory cell lines directly, we included HBEC3-KT in our studies. In comparative analyses, we studied the impact of both the toxin and the toxoid on cell viability, intracellular cAMP concentration and IL-6 secretion. We found that the selected hAEC, which lack CD11b, were differentially susceptible to both CyaA and CyaA-AC–. HBEC3-KT appeared not to be suitable for subsequent analyses. Since the nasal epithelium first gets in contact with airborne pathogens, we further studied the effect of CyaA and its toxoid on the innate immunity of three-dimensional tissue models of the human nasal mucosa. The present study reveals first insights in toxin–cell interaction using primary hAEC.
To study the interaction of human pathogens with their host target structures, human tissue models based on primary cells are considered suitable. Complex tissue models of the human airways have been used as infection models for various viral and bacterial pathogens. The Gram-negative bacterium Bordetella pertussis is of relevant clinical interest since whooping cough has developed into a resurgent infectious disease. In the present study, we created three-dimensional tissue models of the human ciliated nasal and tracheo-bronchial mucosa. We compared the innate immune response of these models towards the B. pertussis virulence factor adenylate cyclase toxin (CyaA) and its enzymatically inactive but fully pore-forming toxoid CyaA-AC\(^-\). Applying molecular biological, histological, and microbiological assays, we found that 1 µg/ml CyaA elevated the intracellular cAMP level but did not disturb the epithelial barrier integrity of nasal and tracheo-bronchial airway mucosa tissue models. Interestingly, CyaA significantly increased interleukin 6, interleukin 8, and human beta defensin 2 secretion in nasal tissue models, whereas tracheo-bronchial tissue models were not significantly affected compared to the controls. Subsequently, we investigated the interaction of B. pertussis with both differentiated primary nasal and tracheo-bronchial tissue models and demonstrated bacterial adherence and invasion without observing host cell type-specific significant differences. Even though the nasal and the tracheo-bronchial mucosa appear similar from a histological perspective, they are differentially susceptible to B. pertussis CyaA in vitro. Our finding that nasal tissue models showed an increased innate immune response towards the B. pertussis virulence factor CyaA compared to tracheo-bronchial tissue models may reflect the key role of the nasal airway mucosa as the first line of defense against airborne pathogens.
Meniscal pathologies are among the most common injuries of the femorotibial joint in both human and equine patients. Pathological forces and ensuing injuries of the cranial horn of the equine medial meniscus are considered analogous to those observed in the human posterior medial horn. Biomechanical properties of human menisci are site-and depth-specific. However, the influence of equine meniscus topography and composition on its biomechanical properties is yet unknown. A better understanding of equine meniscus composition and biomechanics could advance not only veterinary therapies for meniscus degeneration or injuries, but also further substantiate the horse as suitable translational animal model for (human) meniscus tissue engineering. Therefore, the aim of this study was to investigate the composition and structure of the equine knee meniscus in a site-and age-specific manner and their relationship with potential site-specific biomechanical properties. The meniscus architecture was investigated histologically. Biomechanical testing included evaluation of the shore hardness (SH), stiffness and energy loss of the menisci. The SH was found to be subjected to both age and site-specific changes, with an overall higher SH of the tibial meniscus surface and increase in SH with age. Stiffness and energy loss showed neither site nor age related significant differences. The macroscopic and histologic similarities between equine and human menisci described in this study, support continued research in this field.
Alzheimer′s disease (AD) is a neurological disorder with still no preventive or curative treatment. Flavonoids are phytochemicals with potential therapeutic value. Previous studies described the flavanone sterubin isolated from the Californian plant Eriodictyon californicum as a potent neuroprotectant in several in vitro assays. Herein, the resolution of synthetic racemic sterubin (1) into its two enantiomers, (R)‐1 and (S)‐1, is described, which has been performed on a chiral chromatographic phase, and their stereochemical assignment online by HPLC‐ECD coupling. (R)‐1 and (S)‐1 showed comparable neuroprotection in vitro with no significant differences. While the pure stereoisomers were configurationally stable in methanol, fast racemization was observed in the presence of culture medium. We also established the occurrence of extracted sterubin as its pure (S)‐enantiomer. Moreover, the activity of sterubin (1) was investigated for the first time in vivo, in an AD mouse model. Sterubin (1) showed a significant positive impact on short‐ and long‐term memory at low dosages.
Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head
(2012)
Avascular necrosis (AVN) of the femoral head is a debilitating disease of multifactorial genesis, predominately affects young patients, and often leads to the development of secondary osteoarthritis. The evolving field of regenerative medicine offers promising treatment strategies using cells, biomaterial scaffolds, and bioactive factors, which might improve clinical outcome. Early stages of AVN with preserved structural integrity of the subchondral plate are accessible to retrograde surgical procedures, such as core decompression to reduce the intraosseous pressure and to induce bone remodeling. The additive application of concentrated bone marrow aspirates, ex vivo expanded mesenchymal stem cells, and osteogenic or angiogenic growth factors (or both) holds great potential to improve bone regeneration. In contrast, advanced stages of AVN with collapsed subchondral bone require an osteochondral reconstruction to preserve the physiological joint function. Analogously to strategies for osteochondral reconstruction in the knee, anterograde surgical techniques, such as osteochondral transplantation (mosaicplasty), matrix-based autologous chondrocyte implantation, or the use of acellular scaffolds alone, might preserve joint function and reduce the need for hip replacement. This review summarizes recent experimental accomplishments and initial clinical findings in the field of regenerative medicine which apply cells, growth factors, and matrices to address the clinical problem of AVN.
Integrated approaches using different in vitro methods in combination with bioinformatics can (i) increase the success rate and speed of drug development; (ii) improve the accuracy of toxicological risk assessment; and (iii) increase our understanding of disease. Three-dimensional (3D) cell culture models are important building blocks of this strategy which has emerged during the last years. The majority of these models are organotypic, i.e., they aim to reproduce major functions of an organ or organ system. This implies in many cases that more than one cell type forms the 3D structure, and often matrix elements play an important role. This review summarizes the state of the art concerning commonalities of the different models. For instance, the theory of mass transport/metabolite exchange in 3D systems and the special analytical requirements for test endpoints in organotypic cultures are discussed in detail. In the next part, 3D model systems for selected organs liver, lung, skin, brain are presented and characterized in dedicated chapters. Also, 3D approaches to the modeling of tumors are presented and discussed. All chapters give a historical background, illustrate the large variety of approaches, and highlight up- and downsides as well as specific requirements. Moreover, they refer to the application in disease modeling, drug discovery and safety assessment. Finally, consensus recommendations indicate a roadmap for the successful implementation of 3D models in routine screening. It is expected that the use of such models will accelerate progress by reducing error rates and wrong predictions from compound testing.